24 October 2024
24 October 2024
The trial of the Prevail DCB is aimed at treating in-stent restenosis and de novo small vessel disease.
The key drivers of growth in China's medical devices market include the country's ageing population and an increasing number of chronic conditions.
The Roslin Institute spin-out claims that its breast-cancer test saw a 95% specific rating after profiling RNA transcripts that had never been seen before.
The study aims to enrol up to 500 patients with unifocal intermediate-risk prostate cancer worldwide.
The pivotal trial will evaluate the efficacy of the closed-loop insulin device in maintaining optimal blood glucose levels in diabetes patients on multiple daily doses of insulin.
The NIH trial will test treatment combinations targeting genetic changes in acute myeloid leukaemia and myelodysplastic syndromes patients.
The procedures are claimed to have resulted in ‘excellent’ haemodynamics for the initial patients post-operation.
AI can automate repetitive tasks and streamline workflows, allowing physicians to focus on what matters most.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
